CJ Bioscience Inc
KOSDAQ:311690
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2), the stock would be worth ₩9 270.01 (14% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.8 | ₩8 130 |
0%
|
| 3-Year Average | 2 | ₩9 270.01 |
+14%
|
| 5-Year Average | 2.5 | ₩11 276.92 |
+39%
|
| Industry Average | 2.9 | ₩13 214.65 |
+63%
|
| Country Average | 1.1 | ₩5 078.87 |
-38%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
C
|
CJ Bioscience Inc
KOSDAQ:311690
|
106.2B KRW | 1.8 | -3.8 | |
| JP |
|
Medical Data Vision Co Ltd
TSE:3902
|
37.9T JPY | 20.7 | 227.5 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 8 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.3B USD | 3.6 | 28.9 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.4B AUD | 36.7 | 60.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 2.7 | 20.7 | |
| SE |
|
Sectra AB
STO:SECT B
|
50.6B SEK | 26.2 | 94.2 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 1.2 | 42.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.6B USD | 4.7 | 19.1 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 17.2 | -328 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19.1B CNY | 3.3 | -61.9 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2.3 |
| Max | 2 461.2 |
Other Multiples
CJ Bioscience Inc
Glance View
CJ Bioscience, Inc. engages in the research and development of biotechnology and in the provision of solutions for microbiological researches including biomedicine, institutional research and development and genetic sequencing. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-12-26. The firm mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The firm also develops microbiome therapies and infection diagnosis solutions.
